Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

Nutraceutical insulin-sensitizing agents may help treat skin conditions like psoriasis and acne.

Tirzepatide improved symptoms and hair regrowth in a man with folliculitis decalvans.

Early use of infliximab in severe pediatric Crohn's disease can lead to significant improvement and remission.

GLP-1 therapies can cause hair loss, but hair often regrows after stopping or reducing the drug.

Targeting glucocorticoid action might help treat type-2 diabetes, but human trials are needed.

New psoriasis treatments are effective but come with side effects and risks.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

New diabetes tech and therapies improve care for endocrine disorders.

Hormonal treatments can improve acne, but they come with potential side effects and risks.

GLP-1 and GLP-1/GIP agonists may increase the risk of hair loss.

Severe insulin resistance can be managed with medication, lifestyle changes, and treatment for related conditions.

GLP-1RAs, like semaglutide and tirzepatide, may cause hair loss, so patients should be informed and monitored.

New acne treatments show promise as alternatives to traditional therapies.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

Lifestyle changes are more effective than medication for managing PCOS-related risks.

Some drugs linked to growth hormones may increase the chance of hair loss in women.

The document concludes that low-dose acne treatment is most suitable for moderate acne, with high patient satisfaction and low relapse rates.

GLP-1 receptor agonists can cause skin reactions, facial fat loss, and hair loss, but may help with wound healing and skin conditions.

New and repurposed treatments are improving outcomes in dermatology.

Glycemic control medications for Type 2 diabetes can affect skin conditions like psoriasis.

New treatments for skin conditions in children include a preferred drug for birthmark reduction, proactive creams for eczema and vitiligo, a safe psoriasis medication, and special tissues and socks for eczema and fungal infections.

Lifestyle changes are more effective than medication for reducing type 2 diabetes risk.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Insulin-lowering medications show promise for PCOS symptoms but can't be the main treatment yet due to limited long-term research.

Tridax procumbens significantly lowers blood sugar in diabetic rats.

2h-ICPR can help screen for insulin antibodies in type 2 diabetes patients.

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.

Topical sulfonylurea may reduce excessive hair growth caused by certain medications.